Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
- PMID: 11331884
- DOI: 10.1038/35074604
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Abstract
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation. However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation or to transform rodent fibroblasts, indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
Similar articles
-
Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.Mol Cell Biol. 2001 Nov;21(21):7429-41. doi: 10.1128/MCB.21.21.7429-7441.2001. Mol Cell Biol. 2001. PMID: 11585923 Free PMC article.
-
Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.Nat Cell Biol. 2003 May;5(5):427-32. doi: 10.1038/ncb978. Nat Cell Biol. 2003. PMID: 12717443
-
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.Mol Cancer Res. 2002 Nov;1(1):2-11. Mol Cancer Res. 2002. PMID: 12496364
-
Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling.Cell Biochem Biophys. 1999;30(3):369-87. doi: 10.1007/BF02738120. Cell Biochem Biophys. 1999. PMID: 10403057 Review.
-
Signal transfer by Eph receptors.Cell Tissue Res. 1999 Oct;298(1):1-9. Cell Tissue Res. 1999. PMID: 10555534 Review.
Cited by
-
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.J Mol Med (Berl). 2024 Feb 23. doi: 10.1007/s00109-024-02431-x. Online ahead of print. J Mol Med (Berl). 2024. PMID: 38393661 Review.
-
Optogenetic Regulation of EphA1 RTK Activation and Signaling.bioRxiv [Preprint]. 2024 Feb 7:2024.02.06.579139. doi: 10.1101/2024.02.06.579139. bioRxiv. 2024. PMID: 38370612 Free PMC article. Preprint.
-
Eph receptors and ephrins in cancer progression.Nat Rev Cancer. 2024 Jan;24(1):5-27. doi: 10.1038/s41568-023-00634-x. Epub 2023 Nov 23. Nat Rev Cancer. 2024. PMID: 37996538 Review.
-
Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.J Neuroinflammation. 2023 Nov 9;20(1):256. doi: 10.1186/s12974-023-02940-5. J Neuroinflammation. 2023. PMID: 37941008 Free PMC article.
-
Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer.ChemMedChem. 2023 Dec 1;18(23):e202300420. doi: 10.1002/cmdc.202300420. Epub 2023 Oct 5. ChemMedChem. 2023. PMID: 37736700
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
